These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20465508)

  • 1. Efficacy and evaluation of safety of sclerosants for intramuscular venous malformations: clinical and experimental studies.
    Ozaki M; Kurita M; Kaji N; Fujino T; Narushima M; Takushima A; Harii K
    Scand J Plast Reconstr Surg Hand Surg; 2010 Apr; 44(2):75-87. PubMed ID: 20465508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and complications of sclerotherapy for venous malformations.
    Qiu Y; Chen H; Lin X; Hu X; Jin Y; Ma G
    Vasc Endovascular Surg; 2013 Aug; 47(6):454-61. PubMed ID: 23759722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of venous malformations with ethanolamine oleate.
    Das BK; Hoque S
    Asian J Surg; 2008 Oct; 31(4):220-4. PubMed ID: 19010768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck.
    Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
    J Neurointerv Surg; 2014 Nov; 6(9):695-8. PubMed ID: 24235099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck.
    Kaji N; Kurita M; Ozaki M; Takushima A; Harii K; Narushima M; Wakita S
    Scand J Plast Reconstr Surg Hand Surg; 2009; 43(3):126-36. PubMed ID: 19401940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerotherapy in venous malformation.
    Rabe E; Pannier F
    Phlebology; 2013 Mar; 28 Suppl 1():188-91. PubMed ID: 23482557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five adult laryngeal venous malformation cases treated effectively with sclerotherapy.
    Kamijo A; Hatsushika K; Kanemaru S; Moriyama M; Kase Y; Masuyama K
    Laryngoscope; 2013 Nov; 123(11):2766-9. PubMed ID: 23553378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
    Jin Y; Lin X; Li W; Hu X; Ma G; Wang W
    J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures.
    Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI
    AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Macroscopic Haemoglobinuria After Sclerotherapy Using Ethanolamine Oleate for Venous Malformations.
    Fujiki M; Ozaki M; Kurachi I; Iwashina Y; Takushima A
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):105-111. PubMed ID: 31133447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
    Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
    Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of venous malformations with ethanolamine oleate: a descriptive study of 83 cases.
    Hoque S; Das BK
    Pediatr Surg Int; 2011 May; 27(5):527-31. PubMed ID: 21290138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerotherapy with Adjunctive Stasis of Efflux (STASE) in Venous Malformations: Techniques and Strategies.
    Legiehn GM
    Tech Vasc Interv Radiol; 2019 Dec; 22(4):100630. PubMed ID: 31864535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detrimental influences of intraluminally-administered sclerotic agents on surrounding tissues and peripheral nerves: an experimental study.
    Fujiki M; Kurita M; Ozaki M; Kawakami H; Kaji N; Takushima A; Harii K
    J Plast Surg Hand Surg; 2012 Sep; 46(3-4):145-51. PubMed ID: 22686430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
    Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sclerosant with astringent properties developed in China for oesophageal varices: comparison with ethanolamine oleate and polidocanol.
    Nishida R; Inoue R; Takimoto Y; Kita T
    J Gastroenterol Hepatol; 1999 May; 14(5):481-8. PubMed ID: 10355514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate.
    Choi YH; Han MH; O-Ki K; Cha SH; Chang KH
    J Vasc Interv Radiol; 2002 May; 13(5):475-82. PubMed ID: 11997355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular Venous Malformations of the Upper and Lower Limbs: Indications and Outcomes of Sclerotherapy.
    Bianchini G; Camilli D; Furgiuele S
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1505-1512. PubMed ID: 29850938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.